buy

Acadia Pharmaceuticals buy UBS Group AG

Acadia Pharmaceuticals

Start price

€23.07

/ 50%

Target price

06.01.27

Performance (%)

Price

Summary

This prediction is currently active. With a performance of , the BUY prediction for Acadia Pharmaceuticals by UBS_Group_AG is down slightly. This prediction currently runs until 06.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Acadia Pharmaceuticals
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by UBS_Group_AG for this prediction

In the thread Acadia Pharmaceuticals diskutieren

Prediction Buy

Perf. (%)

Target price 34.116

Change

Ends at

ACADIA Pharmaceuticals (NASDAQ:ACAD) was given a new $40.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.

Ratings data for ACAD provided by MarketBeat

UBS Group AG